UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: April 17, 2007
VYTA CORP
---------
(Exact name of registrant as specified in its charter)
Nevada 33-19598-D 84-0992908
------ ---------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification Number)
370 17th Street, Suite 3640,Denver, Colorado 80202
--------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(303) 592-1010
--------------
Registrant's telephone number, including area code
--------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
SECTION 8 - OTHER EVENTS
ITEM 8.01 - OTHER EVENTS
Vyta Corp's ("the Company"), equity investment joint venture Bioagra, LLC
("Bioagra") and AHD International, LLC ("AHD International") of Atlanta,
Georgia, signed an Agreement (the Agreement) whereby AHD International has
agreed to purchase BioAgra's product, AgriStim(TM).
The Agreement has a term of 5 years, beginning on April 1, 2007 and ending
on March 31, 2012 with the right for successive renewals provided minimum sales
requirements are met. According to the terms of the Agreement, AHD International
will be purchasing AgriStim(TM) to resell the product, exclusively and in some
markets non-exclusively to various end users in thirteen countries. AHD
International has exclusive rights to sell AgriStim(TM) in all countries for
human consumption. The Agreement does exclude certain markets and countries,
especially the United States, where Bioagra has focused its sales and marketing
efforts, specifically the poultry, cattle, swine and equine markets. The
Agreement does provide for AHD International to meet certain minimum sales
requirements in order to retain exclusivity in any countries listed in the
Agreement.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS The following is a complete list of exhibits filed as part of
this Report. Exhibit numbers correspond to the numbers in the exhibit table of
Item 601 of Regulation S-B.
EXHIBIT NO. DESCRIPTION
99.01 Agreement by and between Bioagra, LLC and AHD International, LLC,
dated April 1, 2007*
____________________
*Filed herewith
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
VYTA CORP
By: /s/ Paul H. Metzinger
--------------------------------------
Paul H. Metzinger, President and Chief
Executive Officer
Date: April 17, 2007
3